According to the 5-day chart, Northwest Biotherapeutics (NWBO) stock was floating at $1.68 until Wednesday. On this day, the stock fell sharply to $1.54. Then, by Thursday, shares had already risen and on the same day, it went up sharply to $1.73. Now, it trades at $1.74.
Northwest has not made any recent headlines, but many investors are hoping for good news from the firm. Since then, it has applied for accreditation of its facility with the Medicines and Healthcare Products Regulatory Agency (MHRA) (Phase 3 in relation to the treatment of brain cancer).
According to the executives, the entire information will be published in a medical publication in the coming months. The business spent nearly two years preparing the facility for certification with the majority of the work done during the current epidemic.
Finance and Entertainment Reporter
Richard is a bottle of wine – the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.